European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer
Rebecca J. van Kalsbeek(Princess Máxima Center), Renée L. Mulder(Princess Máxima Center), Helena J. H. van der Pal, Roderick Skinner(Royal Victoria Infirmary), Carina Schneider, Riccardo Haupt(Istituto Giannina Gaslini), Tomáš Kepák(Masaryk University), Marlies Mangelschots(KU Leuven), Edit Bárdi(Kepler Universitätsklinikum), Jaap den Hartogh(University of Lucerne), Lars Hjorth(Lund University), Jeanette Falck Winther(Erasmus MC), Monica Muraca(Istituto Giannina Gaslini), Leontien C.M. Kremer(University Medical Center Utrecht), Anne Uyttebroeck(Inserm), Morven C. Brown(Royal Victoria Infirmary), Kateřina Kepáková(Masaryk University), Harun Sabic(Diplomatic Academy of Vienna), Cecilia Follin(Lund University), Rachel Effeney(European Society for Paediatric Oncology), Marleen Renard, Gill Levitt(Great Ormond Street Hospital for Children NHS Foundation Trust), Jacqueline J. Loonen(Radboud University Nijmegen)
Cited by 99
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
|BMC Cancer|2010|755
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724